[1] SEIDLMAYER LK, MAGES C, BERBNER A, et al. Mitofusin 2 Is Essential for IP-Mediated SR/Mitochondria Metabolic Feedback in Ventricular Myocytes[J]. Front Physiol, 2019, 10: 733. doi: 10.3389/fphys.2019.00733
[2] 中华医学会心血管病学分会心力衰竭学组, 中国医师协会心力衰竭专业委员会, 中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10): 760.
[3] 唐碧, 康品方, 郭建路, 等. 线粒体ALDH2对高糖处理的乳鼠心肌成纤维细胞中自噬相关蛋白影响[J]. 南方医科大学学报, 2019, 39(5): 523.
[4] CHEN L, GONG Q, STICE JP, et al. Mitochondrial OPA1, apoptosis, and heart failure[J]. Cardiovasc Res, 2009, 84(1): 91. doi: 10.1093/cvr/cvp181
[5] LI X, WENG X, SHI H, et al. Acetaldehyde dehydrogenase 2 deficiency exacerbates cardiac fibrosis by promoting mobilization and homing of bone marrow fibroblast progenitor cells[J]. J Mol Cell Cardiol, 2019, 137: 107. doi: 10.1016/j.yjmcc.2019.10.006
[6] ZHANG Y, ZHANG L, ZHANG Y, et al. YiQiFuMai powder injection attenuates coronary artery ligation-induced heart failure through improving mitochondrial function via regulating ROS generation and CaMKII signaling pathways[J]. Front Pharmacol, 2019, 10: 381. doi: 10.3389/fphar.2019.00381
[7] XIA CL, CHU P, LIU YX, et al. ALDH2 rs671 polymorphism and the risk of heart failure with preserved ejection fraction (HFpEF) in patients with cardiovascular diseases[J]. J Hum Hypertens, 2020, 34(1): 16. doi: 10.1038/s41371-019-0182-2
[8] 关飞, 方克伟. 线粒体融合蛋白-2生物学功能及其在疾病中作用的研究进展[J]. 山东医药, 2017, 57(38): 106.
[9] CHEN CH, FERREIRA JCB, MOCHLY-ROSEN D. ALDH2 and cardiovascular disease[J]. Adv Exp Med Biol, 2019, 1193: 53.
[10] SAMANGOUEI P, CRESPO-AVILAN GE, CABRERA-FUENTES H, et al. MiD49 and MiD51: New mediators of mitochondrial fission and novel targets for cardioprotection[J]. Cond Med, 2018, 1(5): 239.
[11] 张磊. KLF9调节心脏线粒体代谢功能的分子机制研究[D]. 北京: 北京协和医学院, 2018.
[12] 严凌. 线粒体融合蛋白-2与心血管疾病[J]. 心管病学进展, 2011(32): 276.
[13] ZHAO N, ZHANG Y, LIU Q, et al. Mfn2 Affects Embryo Development via Mitochondrial Dysfunction and Apoptosis[J]. PLoS One, 2015, 10(5): e0125680. doi: 10.1371/journal.pone.0125680
[14] HU L, DING M, TANG D, et al. Targeting mitochondrial dynamics by regulating Mfn2 for he rapeutic interventionindiabetic cardiomyopathy[J]. Theranostics, 2019, 9(13): 3687. doi: 10.7150/thno.33684
[15] YU H, GUO Y, MI L, et al. Mitofusin 2 inhibits angiotensin II-induced myocardial hypertrophy[J]. J Cardiovasc Pharmacol Ther, 2011, 16(2): 205. doi: 10.1177/1074248410385683
[16] MA S, CAO F. Targeting ALDH2 in atherosclerosis: molecular mechanisms and therapeutic opportunities[J]. Adv Exp Med Biol, 2019, 1193: 211.
[17] HUA Y, CHEN H, ZHAO X, et al. Alda-1, an aldehyde dehydrogenase-2 agonist, improves long-term survival in rats with chronic heart failure following myocardial infarction[J]. Mol Med Rep, 2018, 18(3): 3159.
[18] 谷小雨. ALDH2对高糖诱导的心肌成纤维细胞损伤及MMP-14/TIMP-4蛋白的影响[D]. 蚌埠: 蚌埠医学院, 2017.
[19] 刘敏. ALDH2对1型糖尿病致心肌损伤的保护作用及其机制研究[D]. 西安: 第四军医大学, 2015.
[20] LIAO J, SUN A, XIE Y, et al. Aldehyde dehydrogenase-2 deficiency aggravates cardiac dysfunction elicited by endoplasmic reticulum stress induction[J]. Mol Med, 2012, 18(1): 785.
[21] 胡艺川. 乙醛脱氢酶2可减少氧化损伤诱导的心肌细胞凋亡[J]. 基因组学与应用生物学, 2019, 38(3): 1417.
[22] 刘宝山. 乙醛脱氢酶2(ALDH2)的心肌保护作用及调控机制研究[D]. 济南: 山东大学, 2018.
[23] 徐晓晓, 贾如意, 王涛, 等. 半乳糖凝集素-3、可溶性基质溶素-2检测对心力衰竭诊断的相关性研究[J]. 中国循环杂志; 2016, 31(9): 866.